Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.

Abdul Aziz, Nurin; Nash, Sophie Grace; Zaidi, Asad; Nyberg, Tommy; Groves, Natalie; Hope, Russell; Lopez Bernal, Jamie; Dabrera, Gavin; Thelwall, Simon

Abdul Aziz, Nurin; Nash, Sophie Grace; Zaidi, Asad; Nyberg, Tommy; Groves, Natalie; Hope, Russell; Lopez Bernal, Jamie; Dabrera, Gavin; Thelwall, Simon.

Afiliação

Abdul Aziz N; UKHSA COVID-19 Vaccines and Epidemiology Division, UK. Electronic address: iwanibintiabdulaziz@ukhsa.gov.uk.
Nash SG; UKHSA COVID-19 Vaccines and Epidemiology Division, UK.
Zaidi A; UKHSA COVID-19 Vaccines and Epidemiology Division, UK.
Nyberg T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Groves N; UKHSA Genomics and Public Health Analysis, UK.
Hope R; UKHSA HCAI, Fungal, AMR, AMU & Sepsis Division, UK.
Lopez Bernal J; UKHSA COVID-19 Surveillance Cell, UK; NIHR Health Protection Research Unit for Respiratory Infections, UK.
Dabrera G; UKHSA COVID-19 Vaccines and Epidemiology Division, UK.
Thelwall S; UKHSA COVID-19 Vaccines and Epidemiology Division, UK. Electronic address: simon.thelwall@ukhsa.gov.uk.

J Infect ; 87(1): e8-e11, 2023 07.

Article em En | MEDLINE | ID: mdl-37100176

Assuntos

COVID-19; SARS-CoV-2; Humanos; Inglaterra/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google